Journals / Journal of Medicine and Palliative Care / 2023 / Cilt: 4 Sayı: 4

The clinical course of COVID-19 in pregnant and non-pregnant women

Gebe olan ve gebe olmayan kadınlarda COVID-19'un klinik seyri

Pages
263–269
Publication Date
2023-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, mortality rate was also comparable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Pregnancy is a physiological condition that predisposes women to respiratory complications of viral infections thus, bringing the risk of developing more severe disease.
📊
Key Findings & Data:The aim of this research was to elucidate the clinical course of COVID-19 in pregnant and non-pregnant women of childbearing age.
💡
Conclusion & Impact:Additionally, mortality rate was also comparable.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · D-dimer · Gebelik

Abstract

Aim: Pregnancy is a physiological condition that predisposes women to respiratory complications of viral infections thus, bringing the risk of developing more severe disease. The aim of this research was to elucidate the clinical course of COVID-19 in pregnant and non-pregnant women of childbearing age. Mortality rate, laboratory parameters, the occurence of cytokine storm in both groups and the response to treatment have been investigated. Materials and Methods: A total of 88 women of childbearing age with a diagnosis of COVID-19 disease has been retrospectively analyzed. Age, comorbidity, length of stay in the intensive care unit and treatment regimen of patients have been obtained from hospital database. Ferritin, IL-6, CRP, procalcitonin, D-dimer, urea, creatinine, GFR, ALT, AST, LDH, lymphocyte count, neutrophil count, white blood cell count were evaluated. Clinical response such as reduction in oxygen requirement and vasopressor utilization before and after treatment were examined Results: The rate of RT – PCR positive results were statistical significantly higher in pregnant women (p=0.003). The median WBC, lymphocyte and leukocyte values of the pregnant patients were higher (p=0.038, p=0.006 and p=0.035, respectively). The median hemoglobin, LDH and ferritin values of pregnant women were lower than those of non-pregnant individuals (p=0.032, p<0.001 and p=0.010, respectively). Mortality has been observed wit a rate of 17.5% in second trimester and 15% in the third trimester while 22.5% of women in the second trimester and 45% of women in the third trimester have survived COVID-19 infection. Conclusion: Regarding the results of this study, we have observed differences in WBC, lymphocyte and leukocyte, median hemoglobin, LDH and ferritin values of pregnant women and non-pregnant individuals. Additionally, mortality rate was also comparable.

Özet

Amaç: Gebelik, kadınları viral enfeksiyonların solunum yolu komplikasyonlarına yatkınlaştıran ve böylece daha şiddetli hastalık geliştirme riskini getiren fizyolojik bir durumdur. Bu araştırmanın amacı, çocuk doğurma çağındaki gebe olan ve gebe olmayan kadınlarda COVID-19'un klinik seyrini araştırmaktı. Her iki grupta mortalite hızı, laboratuvar parametreleri, sitokin fırtınası oluşumu ve tedaviye yanıt araştırıldı. Gereç ve Yöntemler: COVID-19 hastalığı tanısı almış doğurganlık çağındaki toplam 88 kadın hastanın dosyası retrospektif olarak incelendi. Hastaların yaşı, ek hastalıkları, yoğun bakımda kalış süreleri ve tedavi rejimleri hastane veri tabanından elde edildi. Ferritin, IL-6, CRP, prokalsitonin, D-dimer, üre, kreatinin, GFR, ALT, AST, LDH, lenfosit sayısı, nötrofil sayısı, beyaz küre sayısı değerlendirildi. Tedavi öncesi ve sonrası oksijen ihtiyacında azalma ve vazopresör kullanımı gibi klinik yanıtlar incelendi. Bulgular: Gebelerde RT – PCR pozitif sonuç oranı istatistiksel olarak anlamlı derecede yüksekti (p=0,003). Gebe hastaların medyan WBC, lenfosit ve lökosit değerleri daha yüksekti (sırasıyla, p=0,038, p=0,006 ve p=0,035). Gebelerin medyan hemoglobin, LDH ve ferritin değerleri gebe olmayanlara göre daha düşüktü (sırasıyla p=0,032, p<0,001 ve p=0,010). İkinci trimesterde %17,5, üçüncü trimesterde %15 ölüm oranı gözlenirken, ikinci trimesterde kadınların %22,5'i ve üçüncü trimesterde kadınların %45'i COVID-19 enfeksiyonundan kurtuldu. Sonuç: Bu çalışmanın sonuçlarına bakıldığında, gebe olan ve gebe olmayan hastalar arasında WBC, lenfosit, lökosit, medyan hemoglobin, LDH ve ferritin değerlerinde farklılıklar gözlemlendi. Ek olarak, karşılaştırılabilir ölüm oranı da vardı.

🔖

Cite This Article

SEĞMEN, F., UYSAL, E., KILIÇARSLAN, G., ERDEM, D., ZENGİN, E. N. (2023). The clinical course of COVID-19 in pregnant and non-pregnant women. Journal of Medicine and Palliative Care, Cilt: 4 Sayı: 4, 263–269. https://ajindex.com/articles/959571

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Huang C, Wang Y, Li X, et. al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. World Health Organization. Novel coronavirus ‐ China. Disease outbreak news: Update. 12 January 2020. https://www.who.int/csr/don/12‐january‐2020‐novel‐coronavirus‐china/en/ [Accessed 7 March 2020].
  2. Zengin M, Baldemir R. Investigation of the global outcomes of acute respiratory distress syndrome with the effect of COVID-19 in publications:a bibliometric analysis between 1980 and 2020. Kırıkkale Üniversitesi Tıp Fakültesi Derg 2021:23:279-292.
  3. Zengin M, Karcioglu AM. Do not invade, just support. Bratislavske Lekarske Listy 2022:123;218-226.
  4. Wong SF, Chow KM, Leung TN, et. al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-297.
  5. Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle east respiratory syndrome coronavirus (mers-cov) infection during pregnancy:Report of two cases & review of the literature. J Microbiol Immunol Infect. 2019;52(3):501-503. WHO Director‐General’s opening remarks at the media briefing on COVID‐19 ‐ 3 March 2020. (https://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐atthe‐media‐briefing‐on‐covid‐19‐‐‐3‐march‐2020).
  6. Sutton D, Fuchs K, D’Alton M, Goffman D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med. 2020;382(22):2163-2164.
  7. Breslin N, Baptiste C, Gyamfi-Bannerman C, et. al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women:two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020;2(2):100118. Ellington S, Strid P, Tong VT, et. al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):769-775.
  8. Garg S, Kim L, Whitaker M, et. al. hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458-464.
  9. Di Mascio D, Khalil A, Saccone G, et. al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy:a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal trans